Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.